Case Study: Reducing Renal Progression With SGLT-2 InhibitorsOctober 29th 2021
A case study for a patient who required additional SGLT-2 inhibitors to help reduce progression of renal disease is presented, and Drs Robert Busch, Dhiren Patel, and Muthiah Vadugananthan share their final thoughts on renal protective agents.
Risks and Complications for Chronic Kidney DiseaseOctober 29th 2021
An expert endocrinologist and cardiologist discuss the risks and complications of renal disease associated with diabetes and cardiovascular disease. Dr Robert Busch also provides an overview of some of the studies done in renal impairment.
Case Study: Insulin Pump for Patient With T2DM
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, presents a case study of a patient with type 2 diabetes mellitus, an insulin pump, and a continuous glucose monitor.
Overview of Diabetes and Renal ImpairmentOctober 29th 2021
Dhiren Patel, PharmD, CECES, BC-ADM, Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, provide an overview of the prevalence of renal impairment in patients with diabetes.
Impact of Technology on Diabetes and Quality of Life
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into quality-of-life improvements that have followed advances in diabetes technology and review available continuous glucose monitors.
Improved Metrics for Evaluating Glucose Control in Diabetes
Robert Busch, MD, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discuss metrics to evaluate diabetes control, including time in range and coefficient of variation.
Multidisciplinary Collaboration of Care in Diabetes and Cardiovascular DiseaseOctober 29th 2021
A panel of experts discuss their experience with multidisciplinary collaboration of care between primary care physicians, cardiologists, endocrinologists, and pharmacists in patients with diabetes and cardiovascular disease.
Cardiovascular Disease Guidelines for Diabetes MedicationsOctober 29th 2021
Muthiah Vaduganathan, MD, MPH, provides insight into cardiology guidelines for the use of SGLT-2 [sodium-glucose cotransporter-2] inhibitors and GLP-1 [glucagon-like peptide-1] receptor agonists and discusses the uptake of these medications in patients with and without diabetes.
Continuous Glucose Monitors in Type 1 and Type 2 Diabetes
A panel of experts discuss the impact of continuous glucose monitoring (CGM) on individualized patient care plans for patients with type 1 and type 2 diabetes.
Treatment Goals and Guidelines in Type 2 Diabetes with Cardiovascular DiseaseOctober 29th 2021
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses goals of therapy in diabetic patients with cardiovascular disease and Robert Busch, MD, provides an overview of diabetes treatment guidelines.
Robert Busch, MD, and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into the use of insulin pumps in type 2 diabetes and describe currently available smart pumps.
Role of Technology in Diabetes Care
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide an overview of the pillars of technology utilized in diabetes care: Continuous glucose monitors (CGMs), smart insulin pumps, and connected insulin pens.